BackgroundAtazanavir/ritonavir is recommended as a preferred second-line antiretroviral regimen in children older than 3 months, alternatively to lopinavir/ritonavir. We performed a systematic review
Description and comparison of maternal and infants characteristics according to type of antiretroviral exposure during pregnancy, 2008 to 2011, Cameroon.
Full details of the SelleckChem FDA-approved drug library used for the screening assay as outlined in our manuscript. Dataset includes the names of the 1,954 drugs along with the following information
